2022 annual financial data
Allogene Therapeutics 2022 Operating margin
Allogene Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -138,044.86%.
Operating income was -335,449,000 USD and net income was -329,815,000 USD.
Operating cash flow was -220,519,000 USD.
Get free Allogene Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 243,000 USD
- Operating income
- -335,449,000 USD
- Net income
- -329,815,000 USD
- Operating cash flow
- -220,519,000 USD